Alzheimer's disease and metals: A review of the involvement of cellular membrane receptors in metallosignalling

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Barnham, Kevin J ^a,b   Amadoruge, Pavithra C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; COPPER; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTAMIC ACID; IRON; MATRIX METALLOPROTEINASE; MEMBRANE RECEPTOR; METAL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; REACTIVE OXYGEN METABOLITE; TROPOMYOSIN; TROPOMYOSIN RECEPTOR KINASE; UNCLASSIFIED DRUG; ZINC;

AGING; ALZHEIMER DISEASE; CALCIUM CELL LEVEL; CELL MEMBRANE; CHOLINERGIC SYSTEM; HOMEOSTASIS; HUMAN; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 79955377011     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/542043     Document Type: Review

References (111)

1. Bush A. I., Drug development based on the metals hypothesis of Alzheimer's disease Journal of Alzheimer's Disease 2008 15 2 223 240
2. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Annals of Neurology 1991 30 4 572 580
3. Walsh D. M., Selkoe D. J., Oligomers in the brain: the emerging role of soluble protein aggregates in neurodegeneration Protein and Peptide Letters 2004 11 3 213 228 (Pubitemid 38689025)
4. Kuo Y. M., Emmerling M. R., Vigo-Pelfrey C., Kasunic T. C., Kirkpatrick J. B., Murdoch G. H., Ball M. J., Roher A. E., Water-soluble A (N-40, N-42) oligomers in normal and Alzheimer disease brains Journal of Biological Chemistry 1996 271 8 4077 4081
5. Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., Beach T., Kurth J. H., Rydel R. E., Rogers J., Soluble amyloid peptide concentration as a predictor of synaptic change in Alzheimer's disease American Journal of Pathology 1999 155 3 853 862 (Pubitemid 29426831)
6. Klein W. L., Krafft G. A., Finch C. E., Targeting small A oligomers: the solution to an Alzheimer's disease conundrum? Trends in Neurosciences 2001 24 4 219 224 (Pubitemid 32204378)
7. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
8. Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., Morgan T. E., Rozovsky I., Trommer B., Viola K. L., Wals P., Zhang C., Finch C. E., Krafft G. A., Klein W. L., Diffusible, nonfibrillar ligands derived from A are potent central nervous system neurotoxins Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6448 6453
9. Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J., Selkoe D. J., Naturally secreted oligomers of amyloid protein potently inhibit hippocampal long-term potentiation in vivo Nature 2002 416 6880 535 539 (Pubitemid 34288854)
10. Wang H. W., Pasternak J. F., Kuo H., Ristic H., Lambert M. P., Chromy B., Viola K. L., Klein W. L., Stine W. B., Krafft G. A., Trommer B. L., Soluble oligomers of amyloid (142) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Research 2002 924 2 133 140 (Pubitemid 34102301)
11. Bliss T. V. P., Gardner Medwin A. R., Long lasting potentiation of synaptic transmission in the dentate area of the unanaesthetized rabbit following stimulation of the perforant path Journal of Physiology 1973 232 2 357 374
12. Reddy P. H., Mani G., Park B. S., Jacques J., Murdoch G., Whetsell W., Kaye J., Manczak M., Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction Journal of Alzheimer's Disease 2005 7 2 103 117 (Pubitemid 40592184)
13. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R., Copper, iron and zinc in Alzheimer's disease senile plaques Journal of the Neurological Sciences 1998 158 1 47 52 (Pubitemid 28277534)
14. Frederickson C. J., Klitenick M. A., Manton W. I., Kirkpatrick J. B., Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat Brain Research 1983 273 2 335 339 (Pubitemid 13039719)
15. Barnham K. J., Masters C. L., Bush A. I., Neurodegenerative diseases and oxidatives stress Nature Reviews Drug Discovery 2004 3 3 205 214 (Pubitemid 38379987)
16. White A. A. A. B., The metallobiology of Alzheimer's disease: from bench to clinic. Current medical literature Neurology 2006 22 4 89 97
17. Crouch P. J., Barnham K. J., Bush A. I., White A. R., Therapeutic treatments for Alzheimer's disease based on metal bioavailability Drug News and Perspectives 2006 19 8 469 474 (Pubitemid 46050821)
18. Hynd M. R., Scott H. L., Dodd P. R., Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease Neurochemistry International 2004 45 5 583 595 (Pubitemid 38844879)
19. Eder M., Becker K., Rammes G., Schierloh A., Azad S. C., Zieglgnsberger W., Dodt H. U., Distribution and properties of functional postsynaptic kainate receptors on neocortical layer V pyramidal neurons Journal of Neuroscience 2003 23 16 6660 6670 (Pubitemid 36909892)
20. Lerma J., Roles and rules of kainate receptors in synaptic transmission Nature Reviews Neuroscience 2003 4 6 481 495 (Pubitemid 37280169)
21. Leonard A. S., Lim I. A., Hemsworth D. E., Horne M. C., Hell J. W., Calcium/calmodulin-dependent protein kinase II is associated with the N-methyl-D-aspartate receptor Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3239 3244 (Pubitemid 29148875)
22. Andrsfalvy B. K., Magee J. C., Changes in AMPA receptor currents following LTP induction on rat CA1 pyramidal neurones Journal of Physiology 2004 559 2 543 554 (Pubitemid 39263818)
23. Derkach V., Barria A., Soderling T. R., Ca/calmodulin-kinase II enhances channel conductance of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate type glutamate receptors Proceedings of the National Academy of Sciences of the United States of America 1999 96 6 3269 3274 (Pubitemid 29148880)
24. Wang Z., Edwards J. G., Riley N., Provance D. W., Karcher R., Li X. D., Davison I. G., Ikebe M., Mercer J. A., Kauer J. A., Ehlers M. D., Myosin Vb mobilizes recycling endosomes and AMPA receptors for postsynaptic plasticity Cell 2008 135 3 535 548
25. Bayer K. U., De Koninck P., Leonard A. S., Hell J. W., Schulman H., Interaction with the NMDA receptor locks CaMKII in an active conformation Nature 2001 411 6839 801 805 (Pubitemid 32588103)
26. Lacor P. N., Buniel M. C., Furlow P. W., Clemente A. S., Velasco P. T., Wood M., Viola K. L., Klein W. L., A oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease Journal of Neuroscience 2007 27 4 796 807 (Pubitemid 46174498)
27. Snyder E. M., Nong Y., Almeida C. G., Paul S., Moran T., Choi E. Y., Nairn A. C., Salter M. W., Lombroso P. J., Gouras G. K., Greengard P., Regulation of NMDA receptor trafficking by amyloid- Nature Neuroscience 2005 8 8 1051 1058 (Pubitemid 41061516)
28. Barria A., Malinow R., NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII Neuron 2005 48 2 289 301 (Pubitemid 41476362)
29. Gardoni F., Di Luca M., New targets for pharmacological intervention in the glutamatergic synapse European Journal of Pharmacology 2006 545 1 2 10 (Pubitemid 44215874)
30. Hardingham G. E., Bading H., Coupling of extrasynaptic NMDA receptors to a CREB shut-off pathway is developmentally regulated Biochimica et Biophysica Acta 2002 1600 1-2 148 153 (Pubitemid 38224409)
31. Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H. A., Herms J., Synapse formation and function is modulated by the amyloid precursor protein The Journal of Neuroscience 2006 26 27 7212 7221
32. Deshpande A., Kawai H., Metherate R., Glabe C. G., Busciglio J., A role for synaptic zinc in activity-dependent a oligomer formation and accumulation at excitatory synapses Journal of Neuroscience 2009 29 13 4004 4015
33. Kelly B. L., Ferreira A., -amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons Journal of Biological Chemistry 2006 281 38 28079 28089 (Pubitemid 44414521)
34. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C. M., Stefani M., Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 2002 416 6880 507 511 (Pubitemid 34288846)
35. Zhu Y. J., Lin H., Lal R., Fresh and nonfibrillar amyloid protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for A P-channel-mediated cellular toxicity FASEB Journal 2000 14 9 1244 1254 (Pubitemid 30350406)
36. Kourie J. I., Mechanisms of amyloid protein-induced modification in ion transport systems: implications for neurodegenerative diseases Cellular and Molecular Neurobiology 2001 21 3 173 213 (Pubitemid 32852776)
37. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., Malinow R., AMPAR removal underlies A -induced synaptic depression and sendritic spine loss Neuron 2006 52 5 831 843 (Pubitemid 44828454)
38. Sze C. I., Bi H., Kleinschmidt-DeMasters B. K., Filley C. M., Martin L. J., N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease Journal of the Neurological Sciences 2001 182 2 151 159 (Pubitemid 33786712)
39. Mishizen-Eberz A. J., Rissman R. A., Carter T. L., Ikonomovic M. D., Wolfe B. B., Armstrong D. M., Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology Neurobiology of Disease 2004 15 1 80 92 (Pubitemid 38134383)
40. Hoey S. E., Williams R. J., Perkinton M. S., Synaptic NMDA receptor activation stimulates -secretase amyloid precursor protein processing and inhibits amyloid- Production Journal of Neuroscience 2009 29 14 4442 4460
41. Wu J., Anwyl R., Rowan M. J., -amyloid-(140) increases long-term potentiation in rat hippocampus European Journal of Pharmacology 1995 284 3 R1 R3
42. Chen Q. S., Wei W. Z., Shimahara T., Xie C. W., Alzheimer amyloid -peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus Neurobiology of Learning and Memory 2002 77 3 354 371 (Pubitemid 34971647)
43. Lipton S. A., Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults NeuroRx 2004 1 1 101 110 (Pubitemid 46589343)
44. Vogt K., Mellor J., Tong G., Nicoll R., The actions of synaptically released zinc at hippocampal mossy fiber synapses Neuron 2000 26 1 187 196
45. Li Y., Hough C. J., Suh S. W., Sarvey J. M., Frederickson C. J., Rapid translocation of Zn(2+) from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation Journal of Neurophysiology 2001 86 5 2597 2604 (Pubitemid 34000617)
46. Qian J., Noebels J. L., Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse Journal of Physiology 2005 566 3 747 758 (Pubitemid 41122658)
47. Choi Y. B., Lipton S. A., Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor Neuron 1999 23 1 171 180 (Pubitemid 29262474)
48. Paoletti P., Perin-Dureau F., Fayyazuddin A., Le Goff A., Callebaut I., Neyton J., Molecular organization of a zinc binding N-terminal modulatory domain in a NMDA receptor subunit Neuron 2000 28 3 911 925 (Pubitemid 32038081)
49. Rachline J., Perin-Dureau F., Le Goff A., Neyton J., Paoletti P., The micromolar zinc-binding domain on the NMDA receptor subunit NR2B Journal of Neuroscience 2005 25 2 308 317 (Pubitemid 40105601)
50. Paoletti P., Ascher P., Neyton J., High-affinity zinc inhibition of NMDA NR1-NR2A receptors Journal of Neuroscience 1997 17 15 5711 5725 (Pubitemid 27310487)
51. Mayer M. L., Vyklicky L., Westbrook G. L., Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones Journal of Physiology 1989 415 329 350 (Pubitemid 19205515)
52. Peters S., Koh J., Choi D. W., Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons Science 1987 236 4801 589 593 (Pubitemid 17069929)
53. Westbrook G. L., Mayer M. L., Micromolar concentrations of Zn2+ antagonize NMDA and GABA responses of hippocampal neurons Nature 1987 328 6131 640 643 (Pubitemid 17103970)
54. Li Y., Hough C. J., Frederickson C. J., Sarvey J. M., Induction of mossy fiber→CA3 long-term potentiation requires translocation of synaptically released Zn2+ Journal of Neuroscience 2001 21 20 8015 8025 (Pubitemid 32952758)
55. Sindreu C. B., Varoqui H., Erickson J. D., Prez-Clausell J., Boutons containing vesicular zinc define a subpopulation of synapses with low AMPAR content in rat hippocampus Cerebral Cortex 2003 13 8 823 829 (Pubitemid 36917961)
56. Schlief M. L., Gitlin J. D., Copper homeostasis in the CNS: a novel link between the NMDA receptor and copper homeostasis in the hippocampus Molecular Neurobiology 2006 33 2 81 90 (Pubitemid 43780368)
57. Schlief M. L., Craig A. M., Gitlin J. D., NMDA receptor activation mediates copper homeostasis in hippocampal neurons Journal of Neuroscience 2005 25 1 239 246 (Pubitemid 40110786)
58. Hartter D. E., Barnea A., Evidence for release of copper in the brain: depolarization-induced release of newly taken-up copper Synapse 1988 2 4 412 415
59. Kardos J., Kovacs I., Hajos F., Kalman M., Simonyi M., Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability Neuroscience Letters 1989 103 2 139 144 (Pubitemid 19201242)
60. Barnham K. J., Bush A. I., Metals in Alzheimer's and Parkinson's diseases Current Opinion in Chemical Biology 2008 12 2 222 228
61. Dutar P., Bassant M. H., Senut M. C., Lamour Y., The septohippocampal pathway: structure and function of a central cholinergic system Physiological Reviews 1995 75 2 393 427
62. Winkler J., Suhr S. T., Gage F. H., Thal L. J., Fisher L. J., Essential role of neoecortical acetylcholine in spatial memory Nature 1995 375 6531 484 487
63. Bartus R. T., Dean R. L., Beer B., Lippa A. S., The cholinergic hypothesis of geriatric memory dysfunction Science 1982 217 4558 408 417 (Pubitemid 12048290)
64. Coyle J. T., Price D. L., DeLong M. R., Alzheimer's disease: a disorder of cortical cholinergic innervation Science 1983 219 4589 1184 1190 (Pubitemid 13160659)
65. Goedert M., Tau protein and the neurofibrillary pathology of Alzheimer's disease Trends in Neurosciences 1993 16 11 460 465 (Pubitemid 23313524)
66. Perry E. K., Johnson M., Kerwin J. M., Piggott M. A., Court J. A., Shaw P. J., Ince P. G., Brown A., Perry R. H., Convergent cholinergic activities in aging and Alzheimer's disease Neurobiology of Aging 1992 13 3 393 400
67. Ransmayr G., Cervera P., Hirsch E. C., Berger W., Fischer W., Agid Y., Alzheimer's disease: is the decrease of the cholinergic innervation of the hippocampus related to intrinsic hippocampal pathology? Neuroscience 1992 47 4 843 851
68. Bierer L. M., Haroutunian V., Gabriel S., Knott P. J., Carlin L. S., Purohit D. P., Perl D. P., Schmeidler J., Kanof P., Davis K. L., Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits Journal of Neurochemistry 1995 64 2 749 760
69. Jope R. S., Song L., Powers R. E., Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain Neurobiology of Aging 1997 18 1 111 120 (Pubitemid 27062193)
70. Ladner C. J., Lee J. M., Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited Journal of Neuropathology and Experimental Neurology 1998 57 8 719 731 (Pubitemid 28378149)
71. Pedersen W. A., Kloczewiak M. A., Blusztajn J. K., Amyloid -protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 8068 8071 (Pubitemid 26277166)
72. Boncristiano S., Calhoun M. E., Kelly P. H., Pfeifer M., Bondolfi L., Stalder M., Phinney A. L., Abramowski D., Sturchler-Pierrat C., Enz A., Sommer B., Staufenbiel M., Jucker M., Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis Journal of Neuroscience 2002 22 8 3234 3243 (Pubitemid 35379210)
73. Bowen D. M., Smith C. B., White P., Davison A. N., Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies Brain 1976 99 3 459 496
74. Whitehouse P. J., Price D. L., Struble R. G., Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 1982 215 4537 1237 1239 (Pubitemid 12106486)
75. Vogels O. J. M., Broere C. A. J., Ter Laak H. J., Ten Donkelaar H. J., Nieuwenhuys R., Schulte B. P. M., Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease Neurobiology of Aging 1990 11 1 3 13 (Pubitemid 20097854)
76. Wang H. Y., Lee D. H. S., D'Andrea M. R., Peterson P. A., Shank R. P., Reitz A. B., -amyloid binds to 7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology Journal of Biological Chemistry 2000 275 8 5626 5632 (Pubitemid 30115201)
77. Wang H. Y., Lee D. H. S., Davis C. B., Shank R. P., Amyloid peptide A (142) binds selectively and with picomolar affinity to 7 nicotinic acetylcholine receptors Journal of Neurochemistry 2000 75 3 1155 1161 (Pubitemid 30660505)
78. Wang H. Y., Stucky A., Liu J., Shen C., Trocme-Thibierge C., Morain P., Dissociating -amyloid from 7 nicotinic acetylcholine receptor by a novel therapeutic agent, S 24795, normalizes 7 nicotinic acetylcholine and NMDA receptor function in Alzheimer's disease brain Journal of Neuroscience 2009 29 35 10961 10973
79. Costa L. G., Fox D. A., A selective decrease of cholinergic muscarinic receptors in the visual cortex of adult rats following developmental lead exposure Brain Research 1983 276 2 259 266 (Pubitemid 13009714)
80. Johnson G. V. W., Jope R. S., Aluminum impairs glucose utilization and cholinergic activity in rat brain in vitro Toxicology 1986 40 1 93 102 (Pubitemid 16079879)
81. Webster W. S., Valois A. A., The toxic effects of cadmium on the neonatal mouse CNS Journal of Neuropathology and Experimental Neurology 1981 40 3 247 257 (Pubitemid 12168786)
82. Winder C., Kitchen I., Lead neurotoxicity: a review of the biochemical, neurochemical and drug induced behavioural evidence Progress in Neurobiology 1984 22 1 59 87 (Pubitemid 14143225)
83. Moingeon P., Bidart J. M., Alberici G. F., In vivo modulation of muscarine receptors in rat brain by acute lead intoxication Toxicology 1984 31 2 135 142 (Pubitemid 14123838)
84. Schulte S., Mller W. E., Friedberg K. D., In vivo exposure to lead does not influence muscarinic receptors in the frontal cortex of the mouse brain Toxicology 1994 93 2-3 99 112 (Pubitemid 24350299)
85. Gotti C., Cabrini D., Sher E., Clementi F., Effects of long-term in vitro exposure to aluminum, cadmium or lead on differentiation and cholinergic receptor expression in a human neuroblastoma cell line Cell Biology and Toxicology 1987 3 4 431 440
86. Lewin G. R., Barde Y. A., Physiology of the neurotrophins Annual Review of Neuroscience 1996 19 289 317 (Pubitemid 26080831)
87. Levine E. S., Dreyfus C. F., Black I. B., Plummer M. R., Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors Proceedings of the National Academy of Sciences of the United States of America 1995 92 17 8074 8077
88. Kang H., Schuman E. M., Long-lasting neuratrophin-induced enhancement of synaptic transmission in the adult hippocampus Science 1995 267 5204 1658 1662
89. Chen G., Kolbeck R., Barde Y. A., Bonhoeffer T., Kossel A., Relative contribution of endogenous neurotrophins in hippocampal long- term potentiation Journal of Neuroscience 1999 19 18 7983 7990 (Pubitemid 30225794)
90. Kossel A. H., Cambridge S. B., Wagner U., Bonhoeffer T., A caged Ab reveals an immediate/instructive effect of BDNF during hippocampal synaptic potentiation Proceedings of the National Academy of Sciences of the United States of America 2001 98 25 14702 14707 (Pubitemid 33121455)
91. Barbacid M., Structural and functional properties of the TRK family of neurotrophin receptors Annals of the New York Academy of Sciences 1995 766 442 458 (Pubitemid 26169124)
92. Huang E. J., Reichardt L. F., Trk receptors: roles in neuronal signal transduction Annual Review of Biochemistry 2003 72 609 642 (Pubitemid 36930455)
93. Lee R., Kermani P., Teng K. K., Hempstead B. L., Regulation of cell survival by secreted proneurotrophins Science 2001 294 5548 1945 1948 (Pubitemid 33101595)
94. Lee F. S., Rajagopal R., Kim A. H., Chang P. C., Chao M. V., Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides Journal of Biological Chemistry 2002 277 11 9096 9102 (Pubitemid 34952985)
95. Connor B., Young D., Yan Q., Faull R. L. M., Synek B., Dragunow M., Brain-derived neurotrophic factor is reduced in Alzheimer's disease Molecular Brain Research 1997 49 1-2 71 81 (Pubitemid 27453116)
96. Phillips H. S., Hains J. M., Armanini M., Laramee G. R., Johnson S. A., Winslow J. W., BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease Neuron 1991 7 5 695 702
97. Murray K. D., Gall C. M., Jones E. G., Isackson P. J., Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin- dependent protein kinase messenger RNA expression in Alzheimer's disease Neuroscience 1994 60 1 37 48 (Pubitemid 24147606)
98. Narisawa-Saito M., Wakabayashi K., Tsuji S., Takahashi H., Nawa H., Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease NeuroReport 1996 7 18 2925 2928 (Pubitemid 26426361)
99. Salehi A., Verhaagen J., Dijkhuizen P. A., Swaab D. F., Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease Neuroscience 1996 75 2 373 387 (Pubitemid 26361330)
100. Ferrer I., Marn C., Rey M. J., Ribalta T., Goutan E., Blanco R., Tolosa E., Mart E., BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies Journal of Neuropathology and Experimental Neurology 1999 58 7 729 739 (Pubitemid 29328502)
101. Capsoni S., Tiveron C., Vignone D., Amato G., Cattaneo A., Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration Proceedings of the National Academy of Sciences of the United States of America 2010 107 27 12299 12304
102. Jung J. H., Park M. H., Choi S. Y., Koh J. Y., Activation of the Trk signaling pathway by extracellular zinc. Role of metalloproteinases Journal of Biological Chemistry 2005 280 12 11995 12001 (Pubitemid 40418517)
103. Corona C. E. A., Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction Cell Death and Disease 2010 1, article e91
104. Ross G. M., Shamovsky I. L., Lawrance G., Solc M., Dostaler S. M., Jimmo S. L., Weaver D. F., Riopelle R. J., Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins Nature Medicine 1997 3 8 872 878 (Pubitemid 27353447)
105. Jung J. H., Park MI. H., Koh J. Y., Copper activates TrkB in cortical neurons in a metalloproteinase-dependent manner Journal of Neuroscience Research 2007 85 10 2160 2166 (Pubitemid 47172147)
106. Huang Y. Z., Pan E., Xiong Z. Q., McNamara J. O., Zinc-mediated transactivation of TrkB potentiates the hippocampal mossy fiber-CA3 pyramid synapse Neuron 2008 57 4 546 558 (Pubitemid 351273988)
107. White A. R., Du T., Laughton K. M., Volitakis I., Sharples R. A., Xilinas M. E., Hoke D. E., Holsinger R. M. D., Evin G., Cherny R. A., Hill A. F., Barnham K. J., Li Q. X., Bush A. I., Masters C. L., Degradation of the Alzheimer disease amyloid -peptide by metal-dependent up-regulation of metalloprotease activity Journal of Biological Chemistry 2006 281 26 17670 17680 (Pubitemid 44035565)
108. Donnelly P. S., Caragounis A., Du T., Laughton K. M., Volitakis I., Cherny R. A., Sharples R. A., Hill A. F., Li Q. X., Masters C. L., Barnham K. J., White A. R., Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid- peptide Journal of Biological Chemistry 2008 283 8 4568 4577
109. Crouch P. J., Lin W. H., Adlard P. A., Cortes M., Lal V., Filiz G., Perez K. A., Nurjono M., Caragounis A., Du T., Laughton K., Volitakis I., Bush A. I., Li Q. X., Masters C. L., Cappai R., Cherny R. A., Donnelly P. S., White A. R., Barnham K. J., Increasing Cu bioavailability inhibits A oligomers and tau phosphorylation Proceedings of the National Academy of Sciences of the United States of America 2009 106 2 381 386
110. Price K. A., Filiz G., Caragounis A., Du T., Laughton K. M., Masters C. L., Sharples R. A., Hill A. F., Li Q. X., Donnelly P. S., Barnham K. J., Crouch P. J., White A. R., Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide International Journal of Biochemistry and Cell Biology 2008 40 9 1901 1917
111. Price K. A., Caragounis A., Paterson B. M., Filiz G., Volitakis I., Masters C. L., Barnham K. J., Donnelly P. S., Crouch P. J., White A. R., Sustained activation of glial cell epidermal growth factor receptor by bis(thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity Journal of Medicinal Chemistry 2009 52 21 6606 6620